GLN-ATOVAQUONE

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: 2eff30aebcf85e30
Drug Approval Canada Name: GLN-ATOVAQUONE
Product Name: GLN-ATOVAQUONE
Status: Marketed
Status Date: 2022-06-30
Original Market Date: 2022-06-30
Din: 02528495
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:30.92
Atc Original: P01AX06 ATOVAQUONE
Atc Name: p 01 ax 06
Aig Number: 0124073001
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

ATOVAQUONE

750 MG / 5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2eff30aebcf85e30

Type

Standard